153 related articles for article (PubMed ID: 37025259)
1. Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer.
Huang XD; Huo LQ; Luo YS; Chen K; Li JY; Shi L; Huang L; Cao XP; Ou-Yang Y; Chen FP
Ther Adv Med Oncol; 2023; 15():17588359231165974. PubMed ID: 37025259
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
[TBL] [Abstract][Full Text] [Related]
3. Construction of refined staging classification systems integrating FIGO/T-categories and corpus uterine invasion for non-metastatic cervical cancer.
Huang XD; Chen K; Shi L; Luo YS; Ou-Yang Y; Li JY; Huo LQ; Huang L; Chen FP; Cao XP
Cancer Med; 2023 Jul; 12(14):15079-15089. PubMed ID: 37326385
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
[TBL] [Abstract][Full Text] [Related]
5. The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.
Wu MF; Guan MM; Liu CH; Wu JY; Rao QX; Li J
Cancer Med; 2019 Sep; 8(11):5068-5078. PubMed ID: 31310455
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of preoperative pan-immune-inflammation value (PIV) for prognostication in patients with esophageal squamous cell carcinoma.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Int Immunopharmacol; 2023 Oct; 123():110805. PubMed ID: 37591121
[TBL] [Abstract][Full Text] [Related]
7. A prognostic model using FIGO 2018 staging and MRI-derived tumor volume to predict long-term outcomes in patients with uterine cervical squamous cell carcinoma who received definitive radiotherapy.
Zang L; Chen Q; Lin A; Chen J; Zhang X; Fang Y; Wang M
World J Surg Oncol; 2023 Jul; 21(1):210. PubMed ID: 37475053
[TBL] [Abstract][Full Text] [Related]
8. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
[TBL] [Abstract][Full Text] [Related]
9. Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma.
Huang G; Chen R; Lu N; Chen Q; Lv W; Li B
Onco Targets Ther; 2020; 13():5155-5164. PubMed ID: 32606736
[TBL] [Abstract][Full Text] [Related]
10. Preoperative platelet count improves the prognostic prediction of the FIGO staging system for operable cervical cancer patients.
Zheng RR; Huang XX; Jin C; Zhuang XX; Ye LC; Zheng FY; Lin F
Clin Chim Acta; 2017 Oct; 473():198-203. PubMed ID: 27836106
[TBL] [Abstract][Full Text] [Related]
11. Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System.
Meng Q; Wang W; Liu X; Wang D; Zhang F
Front Oncol; 2022; 12():870670. PubMed ID: 35646645
[TBL] [Abstract][Full Text] [Related]
12. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of preoperative CALLY index for prognostication in patients with esophageal squamous cell carcinoma undergoing surgery.
Feng J; Wang L; Yang X; Chen Q
Sci Rep; 2024 Jan; 14(1):713. PubMed ID: 38184747
[TBL] [Abstract][Full Text] [Related]
14. Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study.
Li Z; Duan H; Guo J; Yang Y; Wang W; Hao M; Li W; Li P; Bin X; Lang J; Liu P; Chen C
Ann Transl Med; 2022 Jan; 10(2):122. PubMed ID: 35282078
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 2 Commercially Systems for Detection of Serum Squamous Cell Carcinoma Antigen in Pan Squamous Cell Carcinoma.
Chen H; Tian L; Chen J; Sun P; Han R; Wu X; Dai S
Cancer Control; 2020; 27(1):1073274820983025. PubMed ID: 33356502
[TBL] [Abstract][Full Text] [Related]
16. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
[TBL] [Abstract][Full Text] [Related]
18. Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases.
Chen FP; Lin L; Liang JH; Tan SH; Ong EHW; Luo YS; Huang L; Sim AYL; Wang HT; Gao TS; Deng B; Zhou GQ; Kou J; Chua MLK; Sun Y
Ther Adv Med Oncol; 2021; 13():17588359211052417. PubMed ID: 34721672
[TBL] [Abstract][Full Text] [Related]
19. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
[TBL] [Abstract][Full Text] [Related]
20. Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy.
Kawaguchi R; Furukawa N; Kobayashi H; Asakawa I
J Gynecol Oncol; 2013 Oct; 24(4):313-20. PubMed ID: 24167666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]